Ambulance steroid shot aims to curb heart attack damage
NCT ID NCT05462730
Summary
This study tested if giving a single, strong dose of an anti-inflammatory steroid (methylprednisolone) in the ambulance could reduce permanent heart damage in people having a major heart attack (STEMI). The goal was to see if quickly calming inflammation during treatment could protect the heart muscle, potentially preventing future heart failure. Researchers enrolled 530 patients to compare the steroid treatment against standard care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOCARDIAL INJURY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Heart Center, Rigshospitalet
Copenhagen, Capital Region, 2100, Denmark
Conditions
Explore the condition pages connected to this study.